3rd Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages HR 1770 - Equitable Community Access to Pharmacist Services Act Issues related to Pharmacy Benefit Managers

LobbyistCovered position, as disclosed
JEFFREY MAXWELL BECKER —
DAVID BOCKORNY —
MARTIN DEPOY —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1770 (118th)

Budget/Appropriations BUD

Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages; HR 1770 Public Law Number 116-136 CARES Act H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes

LobbyistCovered position, as disclosed
JEFFREY MAXWELL BECKER —
DAVID BOCKORNY —
MARTIN DEPOY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1770 (118th), H.R. 1868 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.